How to read: Every bubble is one Indian indomethacin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Indomethacin report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial indomethacin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian indomethacin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Indomethacin India trade report
P
Product scope
Indomethacin
All variants merged — branded and generic formulations of indomethacin
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
159
Every commercial indomethacin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $781.4K, Nov $467.9K, Dec $91.1K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$781.4K
Oct USD
42 shipments
2
$467.9K
Nov USD
-40.1% MoM
3
$91.1K
Dec USD
-80.5% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 40.1% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $781K, making it the strongest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: AFRICURE PHARMACEUTICALS (INDIA) PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import indomethacin from India, how much they buy, and who supplies each market
KEY TAKEAWAYUnited States absorbs 58.2% of India’s 2025-Q4 indomethacin trade ($779.6K). Beyond the top 10 destinations, 38 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 14 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 38 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much indomethacin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$81K
6.1% of trade
14 countries · 74 shipments
Europe
$118K
8.8% of trade
3 countries · 11 shipments
Americas
$829K
61.8% of trade
7 countries · 23 shipments
Africa
$295K
22.0% of trade
13 countries · 47 shipments
Oceania
$17K
1.3% of trade
2 countries · 4 shipments
Fig 4.1 United States is the #1 corridor ($780K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian indomethacin it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
United States
$780K
15
HETERO LABS LTD
$407K
ZYDUS LIFESCIENCES LTD
$292K
GLENMARK PHARMACEUTICALS LTD
$81K
2
France
$118K
5
AJANTA PHARMA LTD
$113K
ALFA BIOMED INDIA PVT LTD
$5K
NIYA HEALTHCARE PVT LTD
$1
3
Mozambique
$77K
2
BDH INDUSTRIES LTD
$77K
—
—
—
—
4
DR Congo
$53K
11
VIDACARE MEDICA PVT LTD
$40K
GALEN PHARMACEUTICALS LTD
$12K
—
—
5
Ethiopia
$49K
3
LEBEN LABORATORIES PVT LTD
$49K
CORAL LABORATORIES LTD
$159
—
—
6
Costa Rica
$48K
1
BLISS GVS PHARMA LTD
$48K
—
—
—
—
7
Tajikistan
$46K
6
SIA PHARMA PVT LTD
$26K
YESHA PHARMACEUTICAL
$11K
DEN MARK PHARMACEUTICALS PVT LTD
$8K
8
Zambia
$28K
2
AFRICURE PHARMACEUTICALS (INDIA) PVT LTD
$22K
JMB PHARMACEUTICALS PVT LTD
$6K
—
—
9
Malawi
$20K
3
LEBEN LABORATORIES PVT LTD
$20K
—
—
—
—
10
Kenya
$17K
8
ANGEL REMEDIES
$10K
AGOG PHARMA LTD
$7K
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 6.1% of USD — but United States is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
58.2%
#1 country share
United States alone
80.3%
Top 5 share
5 of 39 countries
97.8%
Top 15 share
Long tail of 24 countries = 2.2%
HHI 3562
Destination HHI
Highly concentrated
39
Countries served
Global pharma reach from India
14
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
48 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYHETERO LABS LTD ($406.8K, 30.3% share) and ZYDUS LIFESCIENCES LTD ($291.7K) together control 52.1% of India’s 2025-Q4 indomethacin trade. The top 5 suppliers hold 72.6%. 48 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian indomethacin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 HETERO LABS LTD leads by $115K over ZYDUS LIFESCIENCES LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: ZYDUS LIFESCIENCES LTD is #2 by value but #16 by volume.
Fig 5.2 HETERO LABS LTD also leads by shipment count (10) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: ZYDUS LIFESCIENCES LTD moves from #16 by volume to #2 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 48 indomethacin suppliers split into strategic segments
KEY TAKEAWAY12 suppliers (25%) generate 92.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 HETERO LABS LTD and ZYDUS LIFESCIENCES LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 92.1% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
50 importers across 39 countries — who is buying Indian indomethacin and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 64.1% of total USD. 90% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian indomethacin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 ZYDUS PHARMACEUTICALS USA INC is the #1 importer at $292K (21.8%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian indomethacin prices vary by supplier, country and dosage form
KEY TAKEAWAYIndomethacin prices span 8615× ($0.0022 → $18.64). The coefficient of variation is 2.04. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. HETERO LABS LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. AJANTA PHARMA LTDSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. TECH MED DEVICESSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. ZYDUS LIFESCIENCES LTDSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Oct 2025
AGOG PHARMA LTD
Kenya
Capsule
37
$7K
$178.67
Specialty / small-batch
Oct 2025
GLENMARK PHARMAC…
United States
Capsule
1K
$21K
$18.64
Specialty / small-batch
Oct 2025
GLENMARK PHARMAC…
United States
Capsule
1K
$21K
$18.48
Specialty / small-batch
Oct 2025
GLENMARK PHARMAC…
United States
Capsule
1K
$19K
$16.65
Specialty / small-batch
Oct 2025
GLENMARK PHARMAC…
United States
Capsule
1K
$19K
$16.65
Specialty / small-batch
Dec 2025
GLENMARK PHARMAC…
United Arab Emirates
Capsule
3
$48.16
$16.05
Specialty / small-batch
Nov 2025
SANITAS MEDTECH …
Singapore
Capsule
10
$59.84
$5.98
Specialty / small-batch
Oct 2025
J B CHEMICALS AN…
South Africa
Tablet
3K
$16K
$5.52
Specialty / small-batch
Oct 2025
BLISS GVS PHARMA…
Costa Rica
—
9K
$48K
$5.47
Specialty / small-batch
Dec 2025
AFRICURE PHARMAC…
Zambia
Capsule
5K
$22K
$4.51
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
DISTINCT IMPEX P…
Iraq
Tablet
200
$0.433
$0.0022
Bulk generic tablet
Dec 2025
DISTINCT IMPEX P…
Iraq
Tablet
200
$0.433
$0.0022
Bulk generic tablet
Oct 2025
VIDACARE MEDICA …
DR Congo
Capsule
3.0M
$8K
$0.0027
Bulk volume discount
Oct 2025
VIDACARE MEDICA …
DR Congo
Capsule
3.6M
$10K
$0.0028
Bulk volume discount
Oct 2025
VIDACARE MEDICA …
DR Congo
Capsule
2.0M
$6K
$0.0028
Bulk volume discount
Nov 2025
VIDACARE MEDICA …
DR Congo
Capsule
1.7M
$5K
$0.0028
Bulk volume discount
Nov 2025
VIDACARE MEDICA …
DR Congo
Capsule
384K
$1K
$0.0028
Dec 2025
VIDACARE MEDICA …
DR Congo
Capsule
3.0M
$9K
$0.0029
Bulk volume discount
Dec 2025
VIDACARE MEDICA …
DR Congo
Capsule
720K
$2K
$0.0029
Nov 2025
LEBEN LABORATORI…
Sri Lanka
Capsule
2.0M
$7K
$0.0036
Bulk volume discount
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship indomethacin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYIndomethacin leaves India through 13+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), HYDERABAD ICD, MUMBAI AIR (SAHAR)) handle 96.4% of total USD. SEA moves 32% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $513K — top 13 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 32% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$567K
42.3% of USD · 32.1% of ships
AIR
$410K
30.5% of USD · 54.7% of ships
ICD
$349K
26.0% of USD · 10.7% of ships
ROAD
$15K
1.1% of USD · 2.5% of ships
Fig 8.3 The dominant corridor is HYDERABAD ICD → Sea → N. America ($337K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYNetherlands is the most concentrated destination (HHI 10000, 1 suppliers). United States is the most competitive (HHI 4231).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Netherlands (HHI 10,000) is the most concentrated — United States (HHI 4,231) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
ZYDUS PHARMACEUTICAL…
United States
ZYDUS LIFESCIENC…
$292K
1
HIGH
GLENMARK PHARMACEUTI…
United States
GLENMARK PHARMAC…
$81K
4
MEDIUM
PROFARMA LDAAV.OLOF …
Mozambique
BDH INDUSTRIES LTD
$77K
2
MEDIUM
CAMBER PHARMACEUTICA…
United States
HETERO LABS LTD
$70K
3
MEDIUM
KARE PHARMACEUTICALS…
Ethiopia
LEBEN LABORATORI…
$49K
2
MEDIUM
ESVEE MEDICARE LTD
Zambia
AFRICURE PHARMAC…
$22K
1
MEDIUM
PHARMAVET LTD
Malawi
LEBEN LABORATORI…
$20K
3
MEDIUM
BIOTECH LABORATORIES…
South Africa
J B CHEMICALS AN…
$16K
1
MEDIUM
Conclusion: 45 buyers depend on exactly one Indian supplier, representing $737K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST GROUP
United Arab Emirates
3
$6
CLOVERLEAF ECO…
MEDIUM
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
United States
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
France
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Mozambique
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
DR Congo
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Ethiopia
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Costa Rica
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Tajikistan
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Zambia
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Malawi
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Papua New Guinea
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
South Africa
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Somalia
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Uganda
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in United States
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Netherlands lock-ins (HHI 10000)
This Q
MED
A5
Enter United States (3 suppliers)
This Q
HIGH
A6
Enter France (3 suppliers)
This Q
MED
A8
Build France distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
United States
Other
3
$780K
-100%
LOW
Low competition (3 suppliers), accessible market
2
France
Other
3
$118K
-100%
LOW
Low competition (3 suppliers), accessible market
3
Mozambique
Africa
1
$77K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
4
Tajikistan
Asia
3
$46K
+27.1%
LOW
Growing 27% with only 3 competitors
5
DR Congo
Africa
2
$53K
-2.6%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
6
Ethiopia
Africa
2
$49K
-48%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
7
Costa Rica
Other
1
$48K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Zambia
Africa
2
$28K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
9
Malawi
Africa
1
$20K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
10
Kenya
Africa
2
$17K
-51.6%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
11
Papua New Guinea
Other
1
$17K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
South Africa
Africa
1
$16K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Somalia
Africa
4
$16K
-96.1%
LOW
Low competition (4 suppliers), accessible market
14
Uganda
Africa
1
$16K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Sri Lanka
Asia
1
$12K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 159 2025-Q4 Indomethacin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/indomethacin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 159 2025-Q4 indomethacin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian indomethacin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
159
across all regions
TOTAL USD
$1.34M
2025-Q4 FOB value
UNITS
61.2M
tablets, capsules, etc.
SUPPLIERS
48
Indian exporters
BUYERS
50
global importers
COUNTRIES
39
destinations
§10.2 Regional breakdown
Africa
$295K
22.0%
13 ctry · 47 ships
Asia
$81K
6.1%
14 ctry · 74 ships
Europe
$118K
8.8%
3 ctry · 11 ships
Americas
$829K
61.8%
7 ctry · 23 ships
Oceania
$17K
1.3%
2 ctry · 4 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $295K (22.0%), spanning 13 countries.
🏢
48 Indian suppliers shipped to 50 buyers across 39 countries — average shipment value $8K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 48 global indomethacin importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian indomethacin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
ZYDUS PHARMACEUTICALS USA INC
United States
1
$292K
ZYDUS LIFESCIENCES LTD
Suppository
2
GLENMARK PHARMACEUTICALS INC
United States
4
$81K
GLENMARK PHARMACEUTI…
Capsule
3
PROFARMA LDAAV.OLOF PALM N
Mozambique
2
$77K
BDH INDUSTRIES LTD
Capsule
4
CAMBER PHARMACEUTICALS INC
United States
3
$70K
HETERO LABS LTD
Capsule
5
PLANET PHARMA SA
France
3
$70K
AJANTA PHARMA LTD
Eye Drops, Suspension
6
STE PRINCE PHARMA SARL
DR Congo
11
$53K
VIDACARE MEDICA PVT …
Capsule, Suppository
7
KARE PHARMACEUTICALS PLC
Ethiopia
2
$49K
LEBEN LABORATORIES P…
Capsule
8
ESVEE MEDICARE LTD
Zambia
1
$22K
AFRICURE PHARMACEUTI…
Capsule
9
PHARMAVET LTD
Malawi
3
$20K
LEBEN LABORATORIES P…
Capsule
10
BIOTECH LABORATORIES (PTY) LTDDELIV
South Africa
1
$16K
J B CHEMICALS AND PH…
Tablet
11
ROYAL PHARMA 2011 UGANDA LTD
Uganda
1
$16K
AFRICURE PHARMACEUTI…
Capsule
12
M/S.KHALID BIN WALID PHARMACEUTICAL
Somalia
1
$14K
TECH MED DEVICES
Tablet
13
LLC DUNYOISALOMAT
Tajikistan
1
$13K
SIA PHARMA PVT LTD
Ointment
14
CEYOKA (PRIVATE) LTD
Sri Lanka
2
$12K
LEBEN LABORATORIES P…
Capsule
15
7 PHARMACEUTICALS LTD
Papua New Guinea
2
$11K
MOROBE 7 PHARMACEUTI…
Capsule
16
LLC IMDODI SHIFO
Tajikistan
2
$11K
YESHA PHARMACEUTICAL
Ointment
17
KMT PHARMACEUTICAL & MEDICAL SUPP
Bhutan
2
$10K
MEDICO REMEDIES LTD
Capsule
18
GITTOES PHARMACEUTICALS LTD
Kenya
1
$7K
AGOG PHARMA LTD
Capsule
19
PLANET PHARMAZAC DU GRAND LAUNAY,4
France
1
$5K
ALFA BIOMED INDIA PV…
Suspension
20
FATIMA HEALTHCARE LTD
Tanzania
1
$4K
JMB PHARMACEUTICALS …
21
PPS INTERNATIONAL CO LTD
Cambodia
1
$3K
MICRO LABS LTD
Capsule
22
PRIME PHARMA
Somalia
1
$2K
EVEREST HEALTH CARE
Capsule
23
ANPHAR SA DE CV
Honduras
1
$1K
MEDICO REMEDIES LTD
Capsule
24
EMIRATES POST COMPANY
United Arab Emirates
33
$653.04
DERRIC WOOD
Capsule, Tablet
25
AL-NOOR FOR DRUGS & MEDICAL APPLIAN
Yemen
2
$334.50
J.A. UNITED EXPORTS …
Capsule
26
TO AHADU BANK S.C
Ethiopia
1
$159.45
CORAL LABORATORIES LTD
Suppository
27
GULF DRUG LLC
United Arab Emirates
2
$139.87
GLENMARK PHARMACEUTI…
Capsule
28
PRISM INTERNATIONAL LLC
Seychelles
1
$94.87
MEDMALL PHARMACY PVT…
Tablet
29
NASHAAD PHARMA & SURGICAL
Somalia
5
$74.97
RAFAIS
Capsule
30
SUCCESS INTER LINK PTE LTD
Singapore
1
$59.84
SANITAS MEDTECH INST…
Capsule
31
KALKAAL HOSPITAL
Somalia
1
$44.40
CURE EARTH PHARMA
Capsule
32
LIGHT VISION GENERAL TRADING
South Sudan
1
$42.86
BAKER & DAVIS PVT LTD
Capsule
33
KMT PHARMACEUTICAL & MEDICAL SUPPLI
Bhutan
1
$40.96
MEDICO REMEDIES LTD
Capsule
34
THE MASTER OF X PRESS GODAVARI
Netherlands
2
$29.74
3CUBE MEDICARE PVT LTD
Capsule
35
NATIONAL GUARD HOSPITAL
Saudi Arabia
1
$27.54
PROGNOGEN GLOBAL HEA…
Tablet
36
QUEST PHARMACY
Fiji
1
$21.65
P & T PHARMACEUTICAL
Tablet
37
ELJAWABY FOR GENERAL TRADING CO LT
Sudan
1
$21.42
BAKER & DAVIS PVT LTD
Capsule
38
MEDISUITE MEDICAL STORE
United Arab Emirates
1
$14.29
MEDEX PHARMACEUTICALS
Capsule
39
THE MASTER OF ECO TRAMONTANE
Panama
1
$11.38
3CUBE MEDICARE PVT LTD
Capsule
40
JOAN DAVIS
Jamaica
1
$9.36
SHARVIK IMPEX (INDIA…
Capsule
41
THE MASTER OF X PRESS MULHACEN
Netherlands
1
$8.93
3CUBE MEDICARE PVT LTD
Capsule
42
THE MASTER OF X PRESS ELBE
Netherlands
1
$7.77
3CUBE MEDICARE PVT LTD
Suppository
43
THE MASTER OF GH ANGELOU SHIP SPA
South Korea
1
$7.29
3CUBE MEDICARE PVT LTD
Suppository
44
THE MASTER OF SEAL ISLAND SHIP SPAR
Japan
2
$6.26
3CUBE MEDICARE PVT LTD
Suppository
45
EMIRATES POST GROUP
United Arab Emirates
7
$5.83
CLOVERLEAF ECOM PVT …
Tablet
46
THE MASTER OF SKOMER ISLAND
Singapore
1
$4.82
3CUBE MEDICARE PVT LTD
Suppository
47
THE MASTER OF SHELTER ISLAND
Netherlands
1
$2.51
3CUBE MEDICARE PVT LTD
Suppository
48
TO THE INVOICE RAISED TO MANGER OF
Seychelles
1
$0.363
DRIVECURE HEALTHCARE…
Capsule
This report covers 159 2025-Q4 Indomethacin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/indomethacin
Talk to our trade analyst
Need a custom indomethacin report or a deeper dive into any market? Our team is ready.